Statistically more significant galectin 3 serum levels were observed in nulliparous vs. multiparous women (p = 0.043), obese vs. normal body weight patients (p = 0.021), type 2 diabetes patients vs. nontype 2 diabetes patients (p = 0.018), as well as in patients with elevated C-reactive protein (CRP) levels (p = 0.036). Here, LGALS3 is linked to type 2 diabetes mellitus.